- Home
- FOLD vs ALHC Comparison
FOLD vs ALHC Comparison
Compare FOLD & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOLD | ALHC |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FOLD | ALHC |
|---|---|---|
| Price | $14.36 | $19.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $27.25 | $22.59 |
| AVG Volume (30 Days) | ★ 4.2M | 2.1M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.00 | ★ 100.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,948,719,000.00 |
| Revenue This Year | $20.55 | $35.36 |
| Revenue Next Year | $18.34 | $27.13 |
| P/E Ratio | ★ N/A | $405.00 |
| Revenue Growth | N/A | ★ 46.06 |
| 52 Week Low | $5.66 | $11.63 |
| 52 Week High | $14.38 | $23.87 |
Technical Indicators
Market Signals| Indicator | FOLD | ALHC |
|---|---|---|
| Relative Strength Index (RSI) | 73.35 | 42.19 |
| Support Level | $14.21 | $18.50 |
| Resistance Level | $14.37 | $20.40 |
| Average True Range (ATR) | 0.04 | 0.84 |
| MACD | -0.04 | -0.14 |
| Stochastic Oscillator | 93.75 | 36.66 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.